$UG
UNITED GUARDIAN INC

2020 Q3 Form 10-Q Financial Statement

#000117184320007962 Filed on November 13, 2020

View on sec.gov

Income Statement

Concept 2020 Q3 2019 Q3 2019 Q2
Revenue $2.336M $3.317M $3.279M
YoY Change -29.57% -0.81% -15.61%
Cost Of Revenue $974.8K $1.387M $1.467M
YoY Change -29.72% 15.83% -4.52%
Gross Profit $1.362M $1.930M $1.812M
YoY Change -29.47% -10.08% -22.86%
Gross Profit Margin 58.28% 58.19% 55.26%
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development $114.8K $104.8K $93.85K
YoY Change 9.58% 6.61% 2.81%
% of Gross Profit 8.43% 5.43% 5.18%
Depreciation & Amortization $40.00K $50.00K $40.00K
YoY Change -20.0% 25.0% -20.0%
% of Gross Profit 2.94% 2.59% 2.21%
Operating Expenses $114.8K $104.8K $502.1K
YoY Change 9.58% -79.82% -6.05%
Operating Profit $753.6K $1.281M $1.216M
YoY Change -41.19% -16.21% -29.43%
Interest Expense $150.0K $70.00K $140.0K
YoY Change 114.29% -50.0% 250.0%
% of Operating Profit 19.91% 5.46% 11.51%
Other Income/Expense, Net $152.2K $72.82K $136.8K
YoY Change 108.98% -46.92% 246.12%
Pretax Income $905.7K $1.354M $1.353M
YoY Change -33.12% -18.74% -23.25%
Income Tax $188.2K $284.4K $274.1K
% Of Pretax Income 20.78% 21.0% 20.26%
Net Earnings $717.5K $1.070M $1.079M
YoY Change -32.93% -18.74% -22.54%
Net Earnings / Revenue 30.71% 32.25% 32.9%
Basic Earnings Per Share
Diluted Earnings Per Share $156.9K $233.1K $235.3K
COMMON SHARES
Basic Shares Outstanding 4.594M
Diluted Shares Outstanding

Balance Sheet

Concept 2020 Q3 2019 Q3 2019 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $9.030M $9.540M $8.600M
YoY Change -5.35% -4.02% -0.92%
Cash & Equivalents $885.1K $1.795M $910.7K
Short-Term Investments $8.140M $7.740M $7.690M
Other Short-Term Assets $290.0K $270.0K $260.0K
YoY Change 7.41% 80.0% 30.0%
Inventory $1.545M $1.274M $1.301M
Prepaid Expenses
Receivables $1.284M $1.619M $1.533M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $12.15M $12.70M $11.70M
YoY Change -4.35% -4.1% -6.62%
LONG-TERM ASSETS
Property, Plant & Equipment $695.6K $814.1K $782.8K
YoY Change -14.55% -5.75% -11.26%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $3.706K $18.53K $22.24K
YoY Change -80.0% -44.44% -40.0%
Total Long-Term Assets $699.3K $832.6K $805.0K
YoY Change -16.01% -7.19% -12.41%
TOTAL ASSETS
Total Short-Term Assets $12.15M $12.70M $11.70M
Total Long-Term Assets $699.3K $832.6K $805.0K
Total Assets $12.85M $13.53M $12.50M
YoY Change -5.07% -4.3% -7.02%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $40.93K $307.8K $90.45K
YoY Change -86.71% 150.33% -80.89%
Accrued Expenses $1.158M $1.081M $1.364M
YoY Change 7.16% 9.1% 7.55%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.218M $1.529M $1.595M
YoY Change -20.38% 22.3% -15.76%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.218M $1.529M $1.595M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $1.450M $1.760M $1.800M
YoY Change -17.61% 38.58% -4.76%
SHAREHOLDERS EQUITY
Retained Earnings $10.94M $11.31M $10.24M
YoY Change -3.29% -8.86% -7.68%
Common Stock $459.4K $459.4K $459.4K
YoY Change 0.0% 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $11.40M $11.77M $10.70M
YoY Change
Total Liabilities & Shareholders Equity $12.85M $13.53M $12.50M
YoY Change -5.07% -4.3% -7.02%

Cashflow Statement

Concept 2020 Q3 2019 Q3 2019 Q2
OPERATING ACTIVITIES
Net Income $717.5K $1.070M $1.079M
YoY Change -32.93% -18.74% -22.54%
Depreciation, Depletion And Amortization $40.00K $50.00K $40.00K
YoY Change -20.0% 25.0% -20.0%
Cash From Operating Activities -$260.0K $990.0K $1.110M
YoY Change -126.26% -16.81% 5.71%
INVESTING ACTIVITIES
Capital Expenditures -$30.00K -$70.00K -$20.00K
YoY Change -57.14% 133.33% 100.0%
Acquisitions
YoY Change
Other Investing Activities -$1.040M -$20.00K $1.840M
YoY Change 5100.0% -99.53% -54.57%
Cash From Investing Activities -$1.060M -$100.0K $1.820M
YoY Change 960.0% -97.69% -54.84%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 0.000 -2.520M
YoY Change 10.04%
NET CHANGE
Cash From Operating Activities -260.0K 990.0K 1.110M
Cash From Investing Activities -1.060M -100.0K 1.820M
Cash From Financing Activities 0.000 0.000 -2.520M
Net Change In Cash -1.320M 890.0K 410.0K
YoY Change -248.31% -128.34% -85.3%
FREE CASH FLOW
Cash From Operating Activities -$260.0K $990.0K $1.110M
Capital Expenditures -$30.00K -$70.00K -$20.00K
Free Cash Flow -$230.0K $1.060M $1.130M
YoY Change -121.7% -13.11% 6.6%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q3 ug Accrued Annual Report Expenses Current
AccruedAnnualReportExpensesCurrent
47000
CY2019Q4 ug Accrued Annual Report Expenses Current
AccruedAnnualReportExpensesCurrent
64324
CY2020Q3 ug Accrued Distribution Fees Current
AccruedDistributionFeesCurrent
324849
CY2019Q4 ug Accrued Distribution Fees Current
AccruedDistributionFeesCurrent
309190
CY2020Q3 ug Accrued Reserve For Outdated Material
AccruedReserveForOutdatedMaterial
284185
CY2019Q4 ug Accrued Reserve For Outdated Material
AccruedReserveForOutdatedMaterial
231392
CY2020Q3 ug Debt Securities Held To Maturity And Equity Securities Fvni Cost
DebtSecuritiesHeldToMaturityAndEquitySecuritiesFVNICost
7606743
CY2019Q4 ug Debt Securities Held To Maturity And Equity Securities Fvni Cost
DebtSecuritiesHeldToMaturityAndEquitySecuritiesFVNICost
6446276
CY2020Q3 ug Debt Securities Held To Maturity And Equity Securities Fvni Fair Value
DebtSecuritiesHeldToMaturityAndEquitySecuritiesFVNIFairValue
8141897
CY2019Q4 ug Debt Securities Held To Maturity And Equity Securities Fvni Fair Value
DebtSecuritiesHeldToMaturityAndEquitySecuritiesFVNIFairValue
6867516
CY2020Q3 ug Debt Securities Held To Maturity And Equity Securities Fvni Unrealized Gain Loss
DebtSecuritiesHeldToMaturityAndEquitySecuritiesFVNIUnrealizedGainLoss
535154
CY2019Q4 ug Debt Securities Held To Maturity And Equity Securities Fvni Unrealized Gain Loss
DebtSecuritiesHeldToMaturityAndEquitySecuritiesFVNIUnrealizedGainLoss
421240
CY2020Q3 ug Equity Securities Fvni Accumulated Unrealized Gain Loss
EquitySecuritiesFvniAccumulatedUnrealizedGainLoss
535154
CY2019Q4 ug Equity Securities Fvni Accumulated Unrealized Gain Loss
EquitySecuritiesFvniAccumulatedUnrealizedGainLoss
421240
ug Increase Decrease In Dividends Payable
IncreaseDecreaseInDividendsPayable
-124657
ug Increase Decrease In Dividends Payable
IncreaseDecreaseInDividendsPayable
CY2020Q3 ug Payments For Accrued Dividends On Unconverted Shares
PaymentsForAccruedDividendsOnUnconvertedShares
124041
CY2020Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
40925
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
71385
CY2020Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1283595
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2098411
CY2020Q3 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
105000
CY2019Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
216000
CY2020Q3 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
35981
CY2019Q4 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
CY2020Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1158359
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1129126
CY2020Q3 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
25000
CY2019Q4 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
46100
CY2020Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
47750
CY2019Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
48500
CY2020Q3 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
162799
CY2019Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
175433
CY2020Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
6720369
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
6609818
CY2020Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
20186
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
21178
CY2020Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
20186
CY2019Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
21178
CY2020Q3 us-gaap Assets
Assets
12847282
CY2019Q4 us-gaap Assets
Assets
12362812
CY2020Q3 us-gaap Assets Current
AssetsCurrent
12147983
CY2019Q4 us-gaap Assets Current
AssetsCurrent
11567281
us-gaap Basis Of Accounting
BasisOfAccounting
<div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellpadding="0" cellspacing="0" style="; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; min-width: 700px;"> <tr style="vertical-align: top; text-align: justify"> <td style="width: 27pt; text-align: left"><div style="display: inline; font-style: italic; font: inherit;">2.</div></td> <td style="text-align: justify">Basis of Presentation</td> </tr> </table> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: justify">&nbsp;</div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: justify">Interim condensed financial statements of the Company are prepared in accordance with United States Generally Accepted Accounting Principles (&#x201c;US GAAP&#x201d;) for interim financial information, pursuant to the requirements for reporting on Form <div style="display: inline; font-style: italic; font: inherit;">10</div>-Q and Regulation S-<div style="display: inline; font-style: italic; font: inherit;">X.</div> In the opinion of management, all adjustments, including normal recurring accruals, considered necessary for the fair presentation of financial statements for the interim periods have been included. The results of operations for the <div style="display: inline; font-style: italic; font: inherit;">three</div> and <div style="display: inline; font-style: italic; font: inherit;">nine</div> months ended <div style="display: inline; font-style: italic; font: inherit;"> September 30, 2020 (</div>also referred to as the "third quarter of <div style="display: inline; font-style: italic; font: inherit;">2020"</div> and the "first <div style="display: inline; font-style: italic; font: inherit;">nine</div> months of <div style="display: inline; font-style: italic; font: inherit;">2020",</div> respectively) are <div style="display: inline; font-style: italic; font: inherit;">not</div> necessarily indicative of results that ultimately <div style="display: inline; font-style: italic; font: inherit;"> may </div>be achieved for any other interim period or for the year ending <div style="display: inline; font-style: italic; font: inherit;"> December 31, 2020. </div>The interim unaudited condensed financial statements and notes thereto should be read in conjunction with the audited financial statements and notes thereto contained in our Annual Report on Form <div style="display: inline; font-style: italic; font: inherit;">10</div>-K for the year ended <div style="display: inline; font-style: italic; font: inherit;"> December 31, 2019.</div></div></div>
CY2020Q3 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
2842285
CY2019Q4 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
2839289
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
885060
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1048311
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1048311
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
550135
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
885060
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1794583
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-163251
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1244448
CY2020Q3 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
637000
CY2020Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.10
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.10
CY2020Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
10000000
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
10000000
CY2020Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4594319
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4594319
CY2020Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4594319
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4594319
CY2020Q3 us-gaap Common Stock Value
CommonStockValue
459432
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
459432
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-155127
CY2020Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
974763
CY2019Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1386948
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
3634528
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
4142616
CY2020Q3 us-gaap Costs And Expenses
CostsAndExpenses
1582803
CY2019Q3 us-gaap Costs And Expenses
CostsAndExpenses
2035924
us-gaap Costs And Expenses
CostsAndExpenses
5485776
us-gaap Costs And Expenses
CostsAndExpenses
6033152
CY2020Q3 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
81323
CY2019Q3 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
258169
us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
863969
us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
902376
CY2020Q3 us-gaap Debt And Equity Securities Gain Loss
DebtAndEquitySecuritiesGainLoss
113248
CY2019Q3 us-gaap Debt And Equity Securities Gain Loss
DebtAndEquitySecuritiesGainLoss
25499
us-gaap Debt And Equity Securities Gain Loss
DebtAndEquitySecuritiesGainLoss
143832
us-gaap Debt And Equity Securities Gain Loss
DebtAndEquitySecuritiesGainLoss
369542
us-gaap Debt And Equity Securities Realized Gain Loss
DebtAndEquitySecuritiesRealizedGainLoss
29918
us-gaap Debt And Equity Securities Realized Gain Loss
DebtAndEquitySecuritiesRealizedGainLoss
247499
CY2020Q3 us-gaap Debt And Equity Securities Realized Gain Loss
DebtAndEquitySecuritiesRealizedGainLoss
25062
CY2019Q3 us-gaap Debt And Equity Securities Realized Gain Loss
DebtAndEquitySecuritiesRealizedGainLoss
CY2020Q3 us-gaap Debt And Equity Securities Unrealized Gain Loss
DebtAndEquitySecuritiesUnrealizedGainLoss
88186
CY2019Q3 us-gaap Debt And Equity Securities Unrealized Gain Loss
DebtAndEquitySecuritiesUnrealizedGainLoss
25499
us-gaap Debt And Equity Securities Unrealized Gain Loss
DebtAndEquitySecuritiesUnrealizedGainLoss
113914
us-gaap Debt And Equity Securities Unrealized Gain Loss
DebtAndEquitySecuritiesUnrealizedGainLoss
122043
CY2020Q3 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
106882
CY2019Q3 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
26225
us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-155127
us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-18847
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-18847
CY2020Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
231728
CY2019Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
386855
us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
75000
us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
108750
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
121669
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
129625
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
327542
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
825000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
800000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-30460
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
121048
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-815808
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-53659
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
29233
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
40364
CY2020Q3 us-gaap Dividends Payable Current
DividendsPayableCurrent
18536
CY2019Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
142548
CY2020Q3 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
645
CY2019Q3 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
1930
CY2020Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.16
CY2019Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.23
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.59
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.73
CY2020Q3 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
8141897
CY2019Q4 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
3385891
CY2020Q3 us-gaap Equity Securities Fv Ni Cost
EquitySecuritiesFvNiCost
7606743
CY2019Q4 us-gaap Equity Securities Fv Ni Cost
EquitySecuritiesFvNiCost
2964651
CY2020Q3 us-gaap Fixtures And Equipment Gross
FixturesAndEquipmentGross
4504677
CY2019Q4 us-gaap Fixtures And Equipment Gross
FixturesAndEquipmentGross
4482236
CY2019Q4 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
3481625
CY2019Q4 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
3481625
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
905737
CY2019Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
1354265
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
3403292
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
4254904
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
188205
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
284394
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
708842
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
883529
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-208159
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-4185
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
11204
us-gaap Increase Decrease In Prepaid Taxes
IncreaseDecreaseInPrepaidTaxes
-38969
us-gaap Increase Decrease In Prepaid Taxes
IncreaseDecreaseInPrepaidTaxes
-102376
CY2020Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
1040276
CY2019Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
815768
CY2020Q3 us-gaap Inventory Net
InventoryNet
1544819
CY2019Q4 us-gaap Inventory Net
InventoryNet
1217277
CY2020Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
459801
CY2019Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
320507
CY2020Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
35000
CY2019Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
35000
CY2020Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
44742
CY2019Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
81002
CY2020Q3 us-gaap Investment Income Net
InvestmentIncomeNet
38932
CY2019Q3 us-gaap Investment Income Net
InvestmentIncomeNet
47320
us-gaap Investment Income Net
InvestmentIncomeNet
131318
us-gaap Investment Income Net
InvestmentIncomeNet
141428
CY2020Q3 us-gaap Land
Land
69000
CY2019Q4 us-gaap Land
Land
69000
CY2020Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
12847282
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
12362812
CY2020Q3 us-gaap Liabilities Current
LiabilitiesCurrent
1217820
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1343059
CY2020Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
8141897
CY2019Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
6867516
CY2020Q3 us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
113248
CY2019Q3 us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
25499
us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
143832
us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
369542
us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
143832
us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
369542
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1928969
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2524946
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1155986
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
142381
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2921704
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
3627013
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
790307
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
1186611
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
717532
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
1222694
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
1078810
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
1069871
us-gaap Net Income Loss
NetIncomeLoss
2694450
us-gaap Net Income Loss
NetIncomeLoss
3371375
CY2020Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
152180
CY2019Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
72819
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
275150
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
510970
CY2020Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
493204
CY2019Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
544176
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
1520114
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
1593232
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
753557
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
1281446
us-gaap Operating Income Loss
OperatingIncomeLoss
3128142
us-gaap Operating Income Loss
OperatingIncomeLoss
3743934
CY2020Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
17045
CY2019Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
38187
CY2020Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3706
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
14824
us-gaap Payments Of Dividends
PaymentsOfDividends
1928969
us-gaap Payments Of Dividends
PaymentsOfDividends
2524946
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
4932754
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
11112930
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
25437
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
104662
CY2020Q3 us-gaap Pension And Other Postretirement Defined Benefit Plans Current Liabilities
PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities
108750
CY2019Q4 us-gaap Pension And Other Postretirement Defined Benefit Plans Current Liabilities
PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities
CY2020Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
166281
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
170466
CY2020Q3 us-gaap Prepaid Taxes
PrepaidTaxes
126331
CY2019Q4 us-gaap Prepaid Taxes
PrepaidTaxes
165300
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
3802205
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
11359973
CY2020Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
7415962
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
7390525
CY2020Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
695593
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
780707
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-992
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
CY2020Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
114836
CY2019Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
104800
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
331134
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
297304
CY2020Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
10938302
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
10173466
CY2020Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
2336360
CY2019Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
3317370
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
8613918
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
9777086
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
10632898
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
11423505
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
10680202
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
11397734
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
10924938
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
12147632
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
10699566
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
11769437
CY2020Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2019Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2020Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
4594319
CY2019Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
4594319
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
4594319
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
4594319

Files In Submission

Name View Source Status
0001171843-20-007962-index-headers.html Edgar Link pending
0001171843-20-007962-index.html Edgar Link pending
0001171843-20-007962.txt Edgar Link pending
0001171843-20-007962-xbrl.zip Edgar Link pending
exh_311.htm Edgar Link pending
exh_312.htm Edgar Link pending
exh_32.htm Edgar Link pending
f10q_111320p.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
ug-20200930.xml Edgar Link completed
ug-20200930.xsd Edgar Link pending
ug-20200930_cal.xml Edgar Link unprocessable
ug-20200930_def.xml Edgar Link unprocessable
ug-20200930_lab.xml Edgar Link unprocessable
ug-20200930_pre.xml Edgar Link unprocessable